San Francisco- and London-based Aiolos Bio, a newly launched startup with an asthma drug in clinical trials, announced that it raised $245 million in...
Health, Wellness & Biotech
There is only one way to describe this week — incredibly slow. For the first time in a while, there wasn’t a round that hit nine figures. After a...
At least 20 global companies made debuts on the Nasdaq and NYSE in 2021 at initial valuations above $10 billion. Since then, some buzzy names have...
Once again no single investor really dominated the list in September with only one making more than a dozen deals, and just two reaching double...
For weeks it seemed like investors couldn’t take part in enough nine-figure rounds. Well, that all stopped this week, as only one round topped $100...
The big rounds ran the gamut, from parking (yes, parking!) to energy to good ol' AI.
AI, space and biotech were the big winners, raising more than $2 billion in the top five rounds. The last several weeks have definitely seen the big...
There were two raises of $1 billion or more this month, and it took at least $210 million to make this list. Of course, AI played a role.
So far in 2023, Seattle-based startups have pulled in $1.1 billion in seed through growth-stage financing, per SA¹ú¼Ê´«Ã½ data. That’s a decline of...
Vacations are over, everyone’s back in school, football’s here and we are in the full swing of fall. That means some pretty fascinating rounds may...
Venture capitalists have poured hundreds of millions into upstarts aimed at getting livestock, pets, and even people, to consume more bug products.


67.1K Followers